Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Payables: 2023-2024

Historic Payables for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $4.0 million.

  • Upstream Bio's Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
  • Upstream Bio's Payables amounted to $4.0 million in FY2024, which was up 103.07% from $2.0 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Payables ranged from a high of $4.0 million in FY2024 and a low of $2.0 million during FY2023.
  • In the last 2 years, Upstream Bio's Payables had a median value of $3.0 million in 2023 and averaged $3.0 million.
  • Data for Upstream Bio's Payables shows a peak YoY skyrocketed of 103.07% (in 2024) over the last 5 years.
  • Upstream Bio's Payables (Yearly) stood at $2.0 million in 2023, then spiked by 103.07% to $4.0 million in 2024.